|
TCP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.94630000794183E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.13780010255493E-10 |
| Normal-vs-Stage2 |
1.559670E-03 |
| Normal-vs-Stage3 |
9.567000E-01 |
| Normal-vs-Stage4 |
2.616200E-01 |
| Stage1-vs-Stage2 |
6.927600E-01 |
| Stage1-vs-Stage3 |
1.928100E-02 |
| Stage1-vs-Stage4 |
2.310400E-02 |
| Stage2-vs-Stage3 |
6.207500E-02 |
| Stage2-vs-Stage4 |
3.443900E-02 |
| Stage3-vs-Stage4 |
2.786200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37820000359434E-08 |
| Normal-vs-AfricanAmerican |
2.187600E-04 |
| Normal-vs-Asian |
9.490000E-01 |
| Caucasian-vs-AfricanAmerican |
7.652800E-01 |
| Caucasian-vs-Asian |
4.581400E-01 |
| AfricanAmerican-vs-Asian |
4.933800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63779989570401E-10 |
| Normal-vs-Female |
6.683900E-02 |
| Male-vs-Female |
5.364100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.575500E-03 |
| Normal-vs-Extreme_Weight |
1.6521228829447E-12 |
| Normal-vs-Obese |
9.066400E-02 |
| Normal-vs-Extreme_Obese |
2.636400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.447800E-02 |
| Normal_Weight-vs-Obese |
5.424000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.180400E-01 |
| Extreme_Weight-vs-Obese |
4.202700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.228000E-01 |
| Obese-vs-Extreme_Obese |
3.192400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.522800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.66780000005118E-06 |
| Normal-vs-Age(61-80Yrs) |
1.47219999968584E-07 |
| Normal-vs-Age(81-100Yrs) |
5.242100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.972840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.522400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.912300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.507600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.606000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.04638520070921E-12 |
| Normal-VS-Type2 PRCC |
5.397800E-02 |
| Normal-VS-KIRP CIMP |
9.755800E-02 |
| Normal-VS-Unclassified PRCC |
3.64230000000632E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.572000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.964900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.820800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.189980E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.537500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.323800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.07560000023521E-07 |
| Normal-vs-N1 |
6.587800E-02 |
| Normal-vs-N2 |
3.52310000000244E-05 |
| N0-vs-N1 |
1.426220E-04 |
| N0-vs-N2 |
6.507800E-01 |
| N1-vs-N2 |
3.952300E-02 |
|
|
